Insider Transactions in Q3 2025 at Achieve Life Sciences, Inc. (ACHV)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2025
|
Mark K Oki Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,060
-28.12%
|
$100,120
$2.92 P/Share
|
|
Sep 18
2025
|
Mark K Oki Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
168,000
+48.55%
|
-
|
|
Sep 18
2025
|
Richard Alistair Stewart Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
129,501
-36.14%
|
$259,002
$2.92 P/Share
|
|
Sep 18
2025
|
Richard Alistair Stewart Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
297,500
+45.36%
|
-
|
|
Sep 04
2025
|
Thomas Braxton King |
SELL
Open market or private sale
|
Direct |
139,858
-30.74%
|
$279,716
$2.77 P/Share
|
|
Sep 04
2025
|
Thomas Braxton King |
BUY
Exercise of conversion of derivative security
|
Direct |
455,000
+50.0%
|
-
|
|
Sep 04
2025
|
Jerry Wan Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
14,070
-30.09%
|
$28,140
$2.77 P/Share
|
|
Sep 04
2025
|
Jerry Wan Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,100
+42.17%
|
-
|
|
Sep 04
2025
|
Cindy Jacobs President & CMO |
SELL
Open market or private sale
|
Direct |
27,629
-19.29%
|
$55,258
$2.77 P/Share
|
|
Sep 04
2025
|
Cindy Jacobs President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+43.44%
|
-
|
|
Sep 04
2025
|
Jaime Xinos Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,854
-21.89%
|
$41,708
$2.77 P/Share
|
|
Sep 04
2025
|
Jaime Xinos Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,000
+42.0%
|
-
|